Please use this identifier to cite or link to this item: http://hdl.handle.net/1822/62370

TitleBiodegradable polymers: an update on drug delivery in bone and cartilage diseases
Author(s)Lima, Ana Cláudia Fernandes
Ferreira, Helena Susana Costa Machado
Reis, R. L.
Neves, N. M.
KeywordsBiodegradable polymers
Bone diseases
Cartilage diseases
controlled drug release
Drug delivery systems
Targeted drug delivery
Tissue engineering
Issue dateJul-2019
PublisherTaylor and Francis
JournalExpert Opinion on Drug Delivery
CitationLima Ana C., Ferreira H., Reis R. L., Neves N. M. Biodegradable polymers: an update on drug delivery in bone and cartilage diseases, Expert Opinion on Drug Delivery, Vol. 16, Issue 8, pp. 795-813, doi:10.1080/17425247.2019.1635117, 2019
Abstract(s)Introduction: The unique structure of bone and cartilage makes the systemic delivery of free drugs to those connective tissues very challenging. Consequently, effective and targeted delivery for bone and cartilage is of utmost importance. Engineered biodegradable polymers enable designing carriers for a targeted and temporal controlled release of one or more drugs in concentrations within the therapeutic range. Also, tissue engineering strategies can allow drug delivery to advantageously promote the in situ tissue repair. Areas covered: This review article highlights various drug delivery systems (DDS) based on biodegradable biomaterials to treat bone and/or cartilage diseases. We will review their applications in osteoporosis, inflammatory arthritis (namely osteoarthritis and rheumatoid arthritis), cancer and bone and cartilage tissue engineering. Expert opinion: The increased knowledge about biomaterials science and of the pathophysiology of diseases, biomarkers, and targets as well as the development of innovative tools has led to the design of high value-added DDS. However, some challenges persist and are mainly related to an appropriate residence time and a controlled and sustained release over a prolonged period of time of the therapeutic agents. Additionally, the poor prediction value of some preclinical animal models hinders the translation of many formulations into the clinical practice.
TypeArticle
URIhttp://hdl.handle.net/1822/62370
DOI10.1080/17425247.2019.1635117
ISSN1742-5247
e-ISSN1744-7593
Publisher version10.1080/17425247.2019.1635117
Peer-Reviewedyes
AccessOpen access
Appears in Collections:3B’s - Artigos em revistas/Papers in scientific journals

Files in This Item:
File Description SizeFormat 
19960-Biodegradable polymers an update on drug delivery in bone and cartilage diseases.pdf2,05 MBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID